Compound library / Blends
Triple-peptide regenerative stack combining BPC-157 (10mg), TB-500/TB4 (10mg), and Cartalax (10mg) for 30mg total. Extends the "Wolverine Stack" (BPC-157 + TB-500) with Cartalax — a short bioregulatory peptide clinically studied for cartilage regeneration, joint repair, and connective tissue remodeling. Targeted at osteoarthritis, sports injuries, and cartilage/joint wear.
| Category | Blends |
|---|---|
| Regulatory standing | No approved product cited |
| Typical route | Subcutaneous |
| Half-life | Mixed (see individual peptides) |
| Common dose range | 250–500 mcg BPC-157 equivalent per dose; follow product label — typically 1 vial reconstituted and split across 2–4 injections per week |
| Typical cycle length | 8–12 weeks |
BioHack Track models Deadpool Blend at a half-life of 8 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.
No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.
Reconstitute the 30mg vial with 3 mL bacteriostatic water for ~10mg/mL total. Each 0.1 mL draw then delivers ~1mg total — about 0.33mg each of BPC-157, TB-500 and Cartalax.
Store lyophilized powder in freezer. Refrigerate after reconstitution; use within 28 days.
Research compound — not FDA-approved. Components individually have strong safety profiles but human data on this specific blend is limited. BPC-157 + TB-500 (Wolverine Stack) has the most community evidence; Cartalax adds the joint/cartilage angle. Verify vial composition with supplier COA before logging doses.
Track Deadpool Blend in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Deadpool Blend — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.
These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.
Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.